Effectiveness of Influenza Vaccines and Duration of Protection Against Hospitalisation in England: 2022/2023 and 2023/2024 Seasons

Documenti analoghi

• Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom
  di: Heather Whitaker, et al.
  Pubblicazione: (2024)
• Influenza Vaccine Effectiveness Against Symptomatic Influenza in Primary Care: A Test Negative Case Control Study Over Two Influenza Seasons 2022/2023 and 2023/2024 in Ireland
  di: Louise Marron, et al.
  Pubblicazione: (2024)
• Influenza Epidemiology and Vaccine Effectiveness Following Funded Influenza Vaccine in Queensland, Australia, 2022
  di: Ashish C. Shrestha, et al.
  Pubblicazione: (2024)
• Comparative Effectiveness of Cell‐Based Versus Egg‐Based Influenza Vaccines in Prevention of Influenza Hospitalization During the 2022–2023 Season Among Adults 18–64 Years
  di: Emily Rayens, et al.
  Pubblicazione: (2024)
• Excess Respiratory Hospitalisations Associated with Influenza, Respiratory Syncytial Virus and SARS‐CoV‐2 in Singapore from 2015 to 2023
  di: Chia Hui Qi, et al.
  Pubblicazione: (2025)